Born in Turin in 1967, Alberto Bardelli graduated in Biological Sciences in 1991 at the University of the same city and then took a PhD in Biochemistry and Molecular Biology at University College London in the UK. From 1999 to 2004, he specialised in cancer genomics with luminary Bert Vogelstein at the Johns Hopkins University School of Medicine at the Howard Hughes Medical Institute in Baltimore. In 2004, he returned to Italy as director of a research unit dedicated to the study of cancer genomes at the Candiolo Tumour Institute and the Department of Oncology at the University of Turin, where he has been full professor of Histology since 2016. The work of his research group is focused on the development of precision medicine for cancer patients. His discoveries have defined a new diagnostic methodology, called liquid biopsy, which by means of a blood sample, using circulating tumour DNA, makes it possible to monitor the response to therapies and the effectiveness of surgery in colorectal cancer patients. These discoveries are at the basis of international clinical trials such as PEGASUS and CHRONOS. His findings have been published in over 200 scientific articles - including 100 as coordinator - in international journals such as Nature, Science, Cancer Cell, NatureMedicine, JAMA and Lancet Oncology. His H index, a measure of the citations received by his articles, is 98 and, as of 2014, he has been listed by Web of Science as one of the world's most cited researchers. He has been a member of national and international scientific associations such as the European Academy of Cancer Sciences since 2015 and the European Molecular Biology Organisation (EMBO) since 2017, was President of the European Association for Cancer Research (EACR) from 2018 to 2020, and is a member of the AIRC Foundation Scientific Committee for Cancer Research.
Born in Arezzo in 1961, with an economic-business background, a complete manager with significant experience in the management and reorganisation of entities and companies. Solid experience in management control and auditing, have provided valuable support in the role of director and member of Control and Supervisory Bodies. Consulting activities, healthcare and biomedical research, strategic (improving competitive positioning and refocusing core-business), economic (reducing costs, improving profit performance and increasing free cash flow for reinvestment) and tax (reducing taxation through proper and transparent international planning).
Born in Milan in 1963 and graduated in law at the University of Milan, she has been a lawyer since 1992 and a member of the Court of Cassation since 2007. A civil lawyer with a specialisation in family law, she has held and still holds positions in corporate and non-profit contexts. He currently holds the position of Member of the Steering Committee of Fondazione Airc, Member of the Board of Directors of Saes Getters Spa and Member of the Board of Directors of Cogentech srl Società Benefit. From 1 April 2022, he will be Vice President of IFOM, the Institute of Molecular Oncology of the AIRC Foundation.
Reports of suspected violations of the Organisation, Management and Control Model can be made by sending an e-mail to the following address: odv[@]cogentech.eu
Cogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS
Registered Office: via Adamello 16, 20139 Milan, Italy – Fully paid up share Capital 1.100.000 €
Local Unit: c/o Parco Scientifico e Tecnologico della Sicilia S.c.p.a. - Z.I. Blocco Palma I, Stradale V. Lancia, 57 - 95121 Catania
Tax Code, VAT and Milano, Monza, Brianza and Lodi Chamber of Commerce Register n. 04641450962 - R.E.A. MI-1763886
Questo sito web utilizza i cookie, appartenenti a noi o a terzi, per scopi di performance e per pubblicare annunci pubblicitari in linea con le vostre preferenze di navigazione e che possono essere di vostro interesse. Per saperne di più su come utilizziamo i cookie o per modificare le vostre preferenze sui cookie, cliccate su “Impostazioni cookie”. È possibile modificare queste impostazioni in qualsiasi momento visitando la nostra politica sui cookie e seguendo le istruzioni in essa contenute. Facendo clic su “Accetta tutti i cookie”, l’utente accetta la memorizzazione dei cookie sul proprio dispositivo.
Questo cookie è associato a Google Analytics ed è utilizzato per distinguere gli utenti, assegnando a ciascuno di loro un numero generato in modo casuale come identificatore. Viene utilizzato per calcolare il numero di visitatori della pagina, delle sessioni e dei dati al fine di produrre report di analisi statistica anonimizzata.
Questo cookie è associato a Google Analytics ed è utilizzato per distinguere gli utenti, assegnando a ciascuno di loro un numero generato in modo casuale come identificatore. Viene utilizzato per calcolare il numero di visitatori della pagina, delle sessioni e dei dati al fine di produrre report di analisi statistica anonimizzata.
Questo cookie è associato a Google Analytics, è utilizzato per velocizzare le richieste di accesso.
In base alle funzioni implementate, viene utilizzato per registrare le preferenze di utilizzo di tutti gli altri cookie in questo sito. Permette inoltre di modificare le proprie scelte in qualsiasi momento.